Previous 10 | Next 10 |
2023-06-20 01:55:13 ET Summary Assertio is a late-stage pharmaceutical company that has shown significant growth and cost savings under new leadership, focusing on a low-cost, data-driven marketing model. The company's leading product, Indocin, has seen increased sales and a recen...
2023-06-16 20:36:41 ET Summary Share portion of takeover by Assertio Holdings covers the value of the shares plus a merger spread. Contingent value rights on their drug are also included, adding up to $0.20 per share. CVR payout will require aggressive sales growth, but they'r...
2023-06-15 08:05:25 ET Summary Assertio Holdings, a pharmaceutical company, has demonstrated solid financials and growth potential, with a focus on reducing debt levels and increasing cash generation through strategic acquisitions. The company's liquidity position has improved ove...
2023-06-13 17:09:28 ET Summary Assertio was a troubled company at the turn of the decade, embroiled in opioid litigation and losing money. Under new management, the company has switched to a "non-personal" sales model, settled debt, and settled litigation. Sales in 2023 will l...
2023-06-05 21:43:34 ET Summary In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then rebound strongly, with a compound annual growth rate [...
2023-05-26 11:10:38 ET Summary Questions and comments from readers answered. Lookback timeframes identified. Selection of original list of quality stocks from which to select best. Technique of buying and selling after the best stocks are identified. I hadn't ori...
2023-05-24 13:57:04 ET The Russell 3000 index will have a new look on June 26, after the market opens, when 286 securities will be added and 179 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added an...
2023-05-09 23:04:04 ET Assertio Holdings, Inc. (ASRT) Q1 2023 Results Earnings Conference Call May 10, 2023, 04:30 PM ET Company Participants Matt Kreps - Darrow Associates, Investor Relations Dan Peisert - President and Chief Executive Officer Paul Schwichtenber...
2023-05-09 09:12:37 ET Spectrum Pharmaceuticals ( NASDAQ: SPPI ) rose ~10% Tuesday pre-market after the biopharmaceutical company said its Q1 net sales increased by 54% on a quarterly basis. SPPI's net sales for the quarter is $15.6M, compared to $10.1M in the previou...
2023-05-09 08:19:46 ET Summary I present additional information about my methodology for finding the best stocks. Some of the technical tools I use to make final decisions to buy or sell. The leadership of certain stocks and sectors changes occasionally, and we can take this i...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...
LAKE FOREST, Ill., May 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that its Board of...